ESR1 and breast cancer: To test whether these six ZF-TFs could induce fulvestrant-resistant in cells other than MCF7-R73, T47D breast cancer cells, a second fulvestrant-sensitive ER+ human breast cancer line, were individually transduced with each of the six different ZF-TFs and challenged with fulvestrant.